Drugs / AFP gene hepatocellular carcinoma vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00005629 | Jul 1999 → May 2002 | liver cancer | Jonsson Comprehensive Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AFP gene hepatocellular carcinoma vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00005629 ↗ |
| Modality | Vaccine | “three biweekly intradermal vaccinations” NCT00005629 ↗ |
| Route | Other | “three biweekly intradermal vaccinations” NCT00005629 ↗ |